Leishmaniasis, resulting from infection with the protozoan parasite Leishmania, consists of a
wide spectrum of clinical manifestations, from healing cutaneous lesions to fatal visceral …

Veterans of infection, Leishmania parasites have been plaguing mammals for centuries,
causing a morbidity toll second only to that of malaria as the most devastating protozoan …

Although IL-17 is a key factor in Th17 lineage host responses and plays critical roles in
immunological control of a variety of infectious diseases, the contribution of IL-17 to immune …

Purpose The interaction between the Leishmania parasite and the host cell involves
complex, multifaceted processes. The disease severity in cutaneous leishmaniasis (CL) is …

Studies suggest the influence of immune response on the successful treatment of American
tegumentary leishmaniasis (ATL), and indicate the existence of protective immunity in self …

An antileishmanial activity of quinolinic alkaloids from G alipea longiflora Krause, known as
Evanta, has been demonstrated. We have previously shown that, apart from its …

American cutaneous leishmaniasis (ACL) presents distinct active clinical forms with different
grades of severity, known as localised (LCL), intermediate (ICL) and diffuse (DCL) …

A leishmaniose tegumentar americana (LTA) apresenta um amplo espectro de
manifestações clínicas e imunopatológicas resultante da interação entre as diferentes …

Leishmaniasis is an anthropozoonotic, vectorially transmitted disease, which is caused by
different Leishmania species. It is estimated that 350 million people worldwide are at risk of …

Introdução: A forte resposta do tipo Th1, com produção exagerada de IFN-e TNF-α,
observada na leishmaniose tegumentar humana causada por Leishmania braziliensis está …